TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History $0.51 -0.05 (-9.18%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.37 -0.14 (-28.15%) As of 05/2/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Stock Price Performance 5 Day Performance+21.43%1 Month Performance+10.82%3 Month Performance-93.17%6 Month Performance-99.90%Year-To-Date Performance-84.80%1 Year Performance-99.94% Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address RNAZ Stock Chart for Saturday, May, 3, 2025 RNAZ Chart by TradingView TransCode Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$0.56$0.51-9.18%$0.57$0.487.90 million shs$11.96 million05/01/2025$0.41$0.56+38.71%$0.79$0.46130.05 million shs$13.16 million04/30/2025$0.43$0.41-5.88%$0.43$0.391.69 million shs$9.49 million04/29/2025$0.42$0.43+2.42%$0.45$0.411.12 million shs$10.08 million04/28/2025$0.38$0.42+11.00%$0.44$0.383.18 million shs$9.85 million04/25/2025$0.40$0.38-5.00%$0.50$0.387.28 million shs$8.87 million04/24/2025$0.31$0.40+27.39%$0.47$0.3210.17 million shs$9.34 million04/23/2025$0.31$0.31+1.00%$0.35$0.311.95 million shs$7.33 million04/22/2025$0.30$0.31+3.63%$0.33$0.292.32 million shs$7.26 million04/21/2025$0.27$0.30+10.09%$0.39$0.2813.28 million shs$7.00 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$0.27$0.27$0.36$0.225.59 million shs$3.57 million04/17/2025$0.36$0.27-23.58%$0.36$0.225.59 million shs$3.57 million04/16/2025$0.40$0.36-10.40%$0.40$0.352.37 million shs$4.67 million04/15/2025$0.41$0.40-2.93%$0.42$0.38815,510 shs$5.21 million04/14/2025$0.40$0.41+1.49%$0.42$0.361.62 million shs$5.37 million04/11/2025$0.40$0.40+1.35%$0.40$0.371.10 million shs$5.29 million04/10/2025$0.38$0.40+4.48%$0.42$0.342.74 million shs$5.22 million04/09/2025$0.39$0.38-1.68%$0.40$0.351.92 million shs$4.99 million04/09/2025$0.39$0.38-1.68%$0.40$0.351.92 million shs$4.99 million04/08/2025$0.45$0.39-12.81%$0.45$0.371.99 million shs$5.08 million04/08/2025$0.45$0.39-12.81%$0.45$0.371.99 million shs$5.08 million04/07/2025$0.46$0.45-2.88%$0.48$0.411.57 million shs$5.83 million04/04/2025$0.46$0.46-0.87%$0.47$0.383.42 million shs$319,000.0004/03/2025$0.53$0.46-12.54%$0.52$0.462.65 million shs$322,000.0004/02/2025$0.54$0.53-2.29%$0.58$0.483.84 million shs$368,000.00 Related Companies Generation Bio Stock Chart VYNE Therapeutics Stock Chart Daré Bioscience Stock Chart Clene Stock Chart Tempest Therapeutics Stock Chart CytoMed Therapeutics Stock Chart Q32 Bio Stock Chart Lexaria Bioscience Stock Chart Cara Therapeutics Stock Chart Cyclo Therapeutics Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNAZ Stock Free RNAZ Stock Alerts